Homoeopathic management of conduct disorder

Phase 2

Not yet recruiting

• Conditions: Other conduct disorders,

• Registration Number: CTRI/2025/06/089412
• Lead Sponsor: Dr Lenin K S

Brief Summary

This quasi-experimental clinical study evaluates the effectiveness of individualized homoeopathic medicine in reducing the callous unemotional traits in conduct disorder using the inventory callous unemotional Scale (ICU). Secondary objectives include assessing overall improvement in conduct disorder through the Conduct disorder rating scale (CDRS) scale and clinical global improvement (CGI), determining whether homoeopathy helps reducing the callous unemotional traits in conduct disorder. Patients will be recruited from the Outpatient Department (OPD), Inpatient Department (IPD), and Peripheral Centre of the National Homoeopathic Research Institute in Mental Health (NHRIMH), Kottayam, following screening based on DSM 5 criteria. Enrolment requires psychiatric confirmation, and informed consent will be obtained in English and Malayalam. Baseline assessments include ICU for Callous unemotional traits and CDRS for conduct disorder, with evaluations conducted monthly and trio-monthly, respectively, . A detailed case history and mental status examination will be recorded, and individualized homoeopathic remedies will be prescribed based on repertorization via RADAR OPUS software and Homoeopathic Materia Medica. Acute exacerbations will be managed accordingly.  Patients missing follow-ups for three consecutive months will be considered dropouts and will receive standard OPD care but will be excluded from further study evaluation. The study aims to provide clinical evidence on homoeopathy’s role as an reducing the callous unemotional traits in conduct disorder assessing its ability to improve symptoms, enhance quality of life and avoids antisocial personality in future of the affected individuals.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-06-19
• Study Start: 2025-06-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

• Cases satisfying Conduct Disorder diagnostic criteria of DSM-5.
• Age group between 6-18 years of both genders.

Exclusion Criteria

• Children and adolescents suffering from other major known Psychiatric conditions, such as early-onset schizophrenia, autism spectrum disorders, anxiety disorders, and other known serious systemic diseases, including genetic conditions, will be excluded from this study.
• Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in ICU scale denotes reduction in callous-unemotional	Baseline, 3months once
traits, which indicates effectiveness of Individualized Homoeopathic medicine.	Baseline, 3months once

Secondary Outcome Measures

Name	Time	Method
Reduction in CDRS indicates improvement of CD	monthly once
Improvement in the CGI Scale at various time intervals, as mentioned	before,indicates overall improvement of conduct disorder.

Trial Locations

Locations (1)

National Homoeopathy Research Institute in Mental Health; 🇮🇳 Kottayam, KERALA, India

National Homoeopathy Research Institute in Mental Health

🇮🇳Kottayam, KERALA, India

Dr LENIN K S

Principal investigator

9600481609

leninsurendran161@gmail.com